No Data
Insmed To Present at November 2024 Investor Conferences
Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $105
Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC Sponsored ADR (HLN), Insmed (INSM) and Galapagos (GLPG)
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $75 to $105
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $85 to $105
Insmed Price Target Maintained With a $90.00/Share by HC Wainwright & Co.
No Data
No Data